ÂÜÀòÂÒÂ×

Wenbing Gu George is a seasoned professional in the pharmaceutical and healthcare industry, currently serving as Principal & Head of China at Deallus since April 2022. Prior experience includes serving as a Registered Medical Doctor and Consultant for the pharmaceutical and healthcare sector from April 2015 to September 2020, and holding various managerial roles at Eisai, Eli Lilly, and Roche Diagnostic from October 2008 to March 2015, focusing on new product launches and marketing excellence. Earlier in career, Wenbing Gu worked as an oncology physician at Fudan University Zhongshan Hospital from 1995 to 1998. Wenbing Gu holds a Master of Business Administration from The University of Hong Kong and a degree in Medical Science from Fudan University.